Descriptive ACO Materials and Activities Sample Clauses
The "Descriptive ACO Materials and Activities" clause defines the requirements and limitations regarding the use and distribution of materials and activities that describe the Accountable Care Organization (ACO) and its operations. Typically, this clause outlines what types of informational brochures, presentations, or outreach efforts can be used to communicate with stakeholders, such as patients or providers, and may require prior approval or adherence to specific guidelines to ensure accuracy and compliance. Its core function is to ensure that all descriptive materials and activities accurately represent the ACO, thereby preventing misinformation and maintaining regulatory compliance.
Descriptive ACO Materials and Activities.
1. The ACO shall not use, and shall prohibit its Next Generation Participants and Preferred Providers from using Descriptive ACO Materials or Activities until reviewed and approved by CMS.
2. Descriptive ACO Materials or Activities are deemed approved 10 business days following their submission to CMS if:
(a) The ACO certifies in writing its compliance with all the requirements under this Section V.E; and
(b) CMS does not disapprove the Descriptive ACO Materials or Activities.
3. CMS may issue written notice of disapproval of Descriptive ACO Materials or Activities at any time, including after the expiration of the 10 day review period.
4. The ACO, Next Generation Participants, Preferred Providers, or any other individuals or entities performing functions or services related to ACO activities, as applicable, must immediately discontinue use of any Descriptive ACO Materials or Activities disapproved by CMS.
5. Any material changes to CMS-approved Descriptive ACO Materials and Activities must be reviewed and approved by CMS before use.
6. The ACO shall retain copies of all written and electronic Descriptive ACO Materials and Activities and appropriate records for all other Descriptive ACO Materials and Activities provided to Next Generation Beneficiaries in a manner consistent with Section XVIII.
Descriptive ACO Materials and Activities.
1. The ACO shall not use, and shall prohibit its Next Generation Participants and Preferred Providers from using Descriptive ACO Materials or Activities until reviewed and approved by CMS.
2. Descriptive ACO Materials or Activities are deemed approved 10 business days following their submission to CMS if:
(a) The ACO certifies in writing its compliance with all the requirements under this Section V.E; and
(b) CMS does not disapprove the Descriptive ACO Materials or Activities.
3. CMS may issue written notice of disapproval of Descriptive ACO Materials or Activities at any time, including after the expiration of the 10 day review period.